| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0ef5c3365be7092a20772a4b3afd553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0996ed6d8723421db044bf688a02f02b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d41ec0461f1dcf5db85678f027758111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50df8bf686e27b8c155e76218af557a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d37eb461745b8d691065349d29825942
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d1596f64ec0b2dac5334b2cf05b88bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e04826845acea4cc4cdeafc4c2b1e313 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70567 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-32 |
| filingDate |
2008-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c27a8de1f21ba9074f53d9d0718b6d79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ea62ad2e6bfdd6c87e37b3ff036b507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dd96ad47aadce2d0a0fadb933c24695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65e2709a0bd347a45c7ec8c947414e72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a9f68146869d1840e206ed55251227b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_207b861df183b2adb5c677a68981b437 |
| publicationDate |
2008-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008104304-A1 |
| titleOfInvention |
Fabp3 as a biomarker for ppara modulators |
| abstract |
The invention provides FABP3 as a biomarker for PPARa modulators. The invention relates to the identification of a biomarker or a set of biomarkers or a combination of molecular and clinical markers to monitor or identify or quantify a treatment with a PPARa modulator or a combination of one or more PPARa modulators with other pharmacological compounds. |
| priorityDate |
2007-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |